The Senior Director will serve as the senior medical leader for Medical Affairs International Markets, providing strategic direction across medical affairs, evidence generation, scientific engagement, and medical operations while ensuring alignment with Global Medical Affairs, International Markets Commercialization, Clinical Development, Regulatory, Market Access, and other cross-functional partners. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies.